Society for Maternal-fetal Medicine
Based in DC
AI Overview
With $420K in lobbying spend across 33 quarterly filings, Society for Maternal-fetal Medicine is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $80K |
| 2019 | $80K |
| 2020 | $60K |
| 2021 | $40K |
| 2022 | $40K |
| 2023 | $40K |
| 2024 | $40K |
| 2025 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Society for Maternal-fetal Medicine disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations
Preventing Maternal Deaths Act (HR 1318/), Maternal Health Accountability Act (S. 1112), pre-term birth, maternal mental health, Quality Care for Moms and Babies Act (S. 2367/HR 5457), Improving Acces
Labor-HHS-Education Appropriations bill FY2018, Labor-HHS-Education Appropriations bill FY2019, FDA funding, maternal-fetal medicine research; sequestration and non-defense discretionary funding; mate
Preventing Maternal Deaths Act (HR 1318), Maternal Health Accountability Act (S. 1112), pre-term birth, maternal mental health, Quality Care for Moms and Babies Act (S. 2367/HR 5457), Improving Access
Labor-HHS-Education Appropriations bill FY2019, FDA funding, maternal-fetal medicine research; sequestration and non-defense discretionary funding; maternal mental health; opioids; family planning/Tit
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.